![Mark Italia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Italia worked as a Senior Director-Compliance at Gilead Sciences, Inc. and as an Executive Director-Quality & Regulatory Affairs at Imunon, Inc. He holds an MBA degree from Rutgers State University of New Jersey and a doctorate degree from the University of Massachusetts.
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | General Counsel | - |
| IMUNON, INC. | General Counsel | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
